NBP (NovaBridge Biosciences) Accumulated Depreciation: $ Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NBP NovaBridge Biosciences NBP
30 GF Score
Price $1.61
! 5 Warning Signs
View Full Analysis

What is NovaBridge Biosciences Accumulated Depreciation?

NovaBridge Biosciences NBP +0.63% 30 Accumulated Depreciation is $ Mil as of Dec. 2025. GuruFocus rates NBP with a GF Score™ of 30/100. The stock has 5 warning signs investors should review.

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

NovaBridge Biosciences's annual accumulated depreciation declined from Dec. 2023 ($-0.96 Mil) to Dec. 2024 ($-0.22 Mil) but then increased from Dec. 2024 ($-0.22 Mil) to Dec. 2025 ($ Mil).

NovaBridge Biosciences Accumulated Depreciation Related Terms

NovaBridge Biosciences Accumulated Depreciation Historical Data

* Premium members only.

The historical data trend for NovaBridge Biosciences's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NovaBridge Biosciences Accumulated Depreciation Chart

NovaBridge Biosciences Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accumulated Depreciation
Get a 7-Day Free Trial Premium Member Only -6.93 -8.86 -0.96 -0.22 -

NovaBridge Biosciences Quarterly Data
Sep18 Dec18 Sep19 Dec19 Sep20 Dec20 Mar25 Jun25 Sep25 Dec25
Accumulated Depreciation Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -
NBP
30GF Score
NovaBridge Biosciences NBP
Accumulated Depreciation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NovaBridge Biosciences Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

What does a Accumulated Depreciation of $ Mil mean?
NovaBridge Biosciences (NBP) has a Accumulated Depreciation of $ Mil as of Dec. 2025. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on NovaBridge Biosciences and its competitors.
Is NovaBridge Biosciences' Accumulated Depreciation too high?
NovaBridge Biosciences' current Accumulated Depreciation is $ Mil. Overall, NovaBridge Biosciences has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does NovaBridge Biosciences' Accumulated Depreciation compare to PEPG and DTIL?
NovaBridge Biosciences' Accumulated Depreciation of $ Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accumulated Depreciation for a Biotechnology company?
A good Accumulated Depreciation depends on the Biotechnology industry context. However, Accumulated Depreciation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accumulated Depreciation mean?
A high Accumulated Depreciation can signal that a stock is expensive relative to its fundamentals. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on NovaBridge Biosciences and its competitors. NovaBridge Biosciences's current Accumulated Depreciation is $ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NovaBridge Biosciences stock overvalued right now?
NovaBridge Biosciences (NBP) has a current Accumulated Depreciation of $ Mil. The current Accumulated Depreciation is $ Mil. NovaBridge Biosciences' overall GF Score™ is 30/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accumulated Depreciation calculated?
Accumulated Depreciation is calculated from a company's financial statements. For NovaBridge Biosciences (NBP), the current Accumulated Depreciation is $ Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

NovaBridge Biosciences Business Description

Other Exchanges 0VY:Germany
Address 2440 Research Boulevard, Suite 400, Rockville, MD, USA, 20850
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. Its inventive immuno-oncology pipeline consists of three clinical stage programs, givastomig; uliledlimab; and ragistomig. Its core product, givastomig, is a potential in-class CLDN18.2 bispecific antibody for the treatment of gastric cancer and other CLDN18.2-positive gastrointestinal malignancies.
30GF Score

Get the complete analysis for NBP

Accumulated Depreciation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.61
Price